DOE-01
N/A
Report date: 2022/11/16 12:20:09
NME
Base Information
Drug NameDOE-01
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTianjin Pharmaceutical Research Institute Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTianjin Pharmaceutical Research Institute Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A